· Published by Health Canada · Official notice
This is duplicated text of a letter from Pharmaceutical Partners of Canada Inc. (PPC). Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
May 17, 2013
Dear Health Care Professional,
Subject: Recall of Magnesium Sulfate Injection, USP 50%, 50 mL vial, Lot 6103881, expiry date October 2014, due to potential for glass particles
Pharmaceutical Partners of Canada Inc. (PPC), in consultation with Health Canada, has initiated a voluntary recall of Magnesium Sulfate Injection, USP Lot 6103881 (DIN 02139499) due to potential for glass particles. Recent inspection carried out on retention samples by the manufacturer revealed that the product with above mentioned lot number may contain glass particles. The affected lot has been distributed on the Canadian market from June 12, 2012 to July 30, 2012.
Magnesium Sulfate Injection, USP is indicated as a CNS depressant, primarily in preeclampsia and eclampsia of pregnancy and as an electrolyte replenisher for hypomagnesemia and magnesium deficiency to maintain normal neuromuscular irritability.
Injected glass particles may result in phlebitis, acute inflammation, allergic reaction, and/or embolization to other organs in the body.
Managing marketed health product-related adverse reactions depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-marketing adverse reactions are generally presumed to underestimate the risks associated with health product treatments. Any case of serious or other serious or unexpected adverse reactions in patients receiving Magnesium Sulfate Injection Lot 6103881 should be reported to Pharmaceutical Partners of Canada Inc. or Health Canada.
Pharmaceutical Partners of Canada Inc.
45 Vogell Road
Richmond Hill, ON
L4B 3P6
You can report any suspected adverse reactions associated with the use of health products, to Health Canada by:
For other health product inquiries related to this communication, contact Health Canada at:
Health Product and Food Branch Inspectorate
E-mail: DCVIU_UVECM@hc-sc.gc.ca
Tel: 1-800-267-9676
Fax: 613-946-5636
Sincerely,
original signed by
Jim Walker
Vice President Scientific Affairs